12 results
DEFA14A
ALKS
Alkermes plc
13 Jun 23
Additional proxy soliciting materials
7:08am
at UConn (current), Chief Executive Officer of the Cato T. Laurencin Institute for Regenerative Engineering (current), Editor-in-Chief of the Journal
DEFA14A
ALKS
Alkermes plc
7 Jun 23
Additional proxy soliciting materials
5:28pm
. Laurencin, M.D., Ph.D. – Independent Director CEO, Cato T. Laurencin Institute for Regenerative Engineering University Professor at University of Connecticut
DEFC14A
ALKS
Alkermes plc
25 May 23
Proxy in contested solicitation
4:03pm
for Regenerative Engineering. Dr. Laurencin previously served as Vice President for Health Affairs and Dean of the School of Medicine at UConn. Dr. Laurencin … is a pioneer in the field of regenerative engineering, and an expert in biomaterials science, stem cell technology and nanotechnology. He currently serves
PRER14A
6ny 4ofmv
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
tc5niz5csb5h
8 May 23
Preliminary proxy with contested solicitation
4:34pm
DEFC14A
iaa3yxspnzlhau
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
3fx89m
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-99.1
8e2 hgo1n7
19 Nov 21
Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors
7:08am
- Prev
- 1
- Next